Application of ablative therapy for intrahepatic recurrent hepatocellular carcinoma following hepatectomy

doi:10.4240/wjgs.v15.i1.9

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 1

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3010)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-1) series.

Item

Count

PDF

116

WORD

HTML

1088

Figures (1-1)

162

Tables (1-1)

151

Sum=1549

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

175

Download

485

Sum=660

Publishing Process of This Article

Item

Count

Browse

188

Download

613

Sum=801

Jan 27, 2023 (publication date) through Apr 25, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Surgery

ISSN

1948-9366

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Gastrointest Surg. Jan 27, 2023; 15(1): 9-18
Published online Jan 27, 2023. doi: 10.4240/wjgs.v15.i1.9

Open in New Tab Full Size Figure Download Figure

Figure 1 Role of ablation in intrahepatic recurrent hepatocellular carcinoma. HCC: Hepatocellular carcinoma; TACE: Transarterial chemoembolization; RFA: Radiofrequency ablation; MWA: Microwave ablation; PEI: Percutaneous ethanol injection; HIFU: High-intensity focused ultrasound ablation; CRA: Cryoablation; IRE: Irreversible electroporation.

Citation: Cong R, Ma XH, Wang S, Feng B, Cai W, Chen ZW, Zhao XM. Application of ablative therapy for intrahepatic recurrent hepatocellular carcinoma following hepatectomy. World J Gastrointest Surg 2023; 15(1): 9-18
URL: https://www.wjgnet.com/1948-9366/full/v15/i1/9.htm
DOI: https://dx.doi.org/10.4240/wjgs.v15.i1.9